跳至主要内容
临床试验/IRCT20200310046736N1
IRCT20200310046736N1尚未招募2 期

Comparison of The Therapeutic Effect of Convalescent Plasma and Plasma-derived Immunoglobulin-enriched solution on COVID-19 Patients: A Clinical Trial Study

Ahvaz University of Medical Sciences0 个研究点目标入组 45 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
入组人数
45

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 years 至 45 years(—)
性别
All

入选标准

  • COVID-19 Patients who have the clinical signs of COVIDE-19 infection such as fever, cough, sputum production, sore throat, and so on.
  • Patients with the positive CT scan
  • Patients who declare Informed Consent for this study.

排除标准

  • Pregnant Women (based on WHO protocol)
  • Lactating Women (based on WHO protocol)
  • Individuals who exhibit specific allergic reactions to intravenous administration.
  • Patients with/or with a history of dangerous underlying diseases such as IgA deficiency
  • Patients with/or with a history of dangerous diseases such as cardiovascular and or hematological disorders (hemophilia, thalassemia, leukemia).
  • Patients with/or with a history of underlying diseases such as liver and kidney disease

研究者

相似试验